Back to News
Market Impact: 0.2
How Much Upside is Left in Tarsus Pharmaceuticals (TARS)? Wall Street Analysts Think 30.78%
Source: zacks.com
Analyst InsightsAnalyst Estimates
Wall Street analysts’ average price target implies 30.8% potential upside for Tarsus Pharmaceuticals (TARS). The article cautions that price targets may be an unreliable metric, while positive earnings estimate revisions could support the stock.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
TARS0.30
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Why is Apple stock falling afterhours today?
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- RA Capital Management sells $9.13M in Lenz Therapeutics shares